Dearborn Partners’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.61M | Sell |
46,112
-4,579
| -9% | -$369K | 0.2% | 80 |
|
|
2026
Q1 | $4.39M | Sell |
50,691
-2,545
| -5% | -$244K | 0.24% | 72 |
|
|
2025
Q4 | $5.11M | Sell |
53,236
-2,114
| -4% | -$205K | 0.26% | 67 |
|
|
2025
Q3 | $5.27M | Sell |
55,350
-4,837
| -8% | -$445K | 0.25% | 66 |
|
|
2025
Q2 | $5.25M | Buy |
60,187
+1,337
| +2% | +$113K | 0.25% | 66 |
|
|
2025
Q1 | $5.29M | Sell |
58,850
-13,177
| -18% | -$1.18M | 0.25% | 70 |
|
|
2024
Q4 | $5.75M | Buy |
72,027
+5,252
| +8% | +$455K | 0.24% | 71 |
|
|
2024
Q3 | $6.01M | Sell |
66,775
-2,117
| -3% | -$178K | 0.24% | 71 |
|
|
2024
Q2 | $5.42M | Sell |
68,892
-3,077
| -4% | -$252K | 0.23% | 70 |
|
|
2024
Q1 | $6.27M | Sell |
71,969
-29,993
| -29% | -$2.56M | 0.27% | 69 |
|
|
2023
Q4 | $8.4M | Sell |
101,962
-146
| -0.1% | -$11.1K | 0.31% | 66 |
|
|
2023
Q3 | $8M | Buy |
102,108
+802
| +0.8% | +$67.1K | 0.31% | 66 |
|
|
2023
Q2 | $8.93M | Buy |
101,306
+90,402
| +829% | +$7.78M | 0.34% | 64 |
|
|
2023
Q1 | $879K | Sell |
10,904
-2,334
| -18% | -$190K | 0.03% | 121 |
|
|
2022
Q4 | $1.03M | Buy |
13,238
+930
| +8% | +$75.4K | 0.04% | 113 |
|
|
2022
Q3 | $994K | Buy |
12,308
+207
| +2% | +$18.6K | 0.04% | 110 |
|
|
2022
Q2 | $1.09M | Buy |
12,101
+1,134
| +10% | +$115K | 0.05% | 109 |
|
|
2022
Q1 | $1.22M | Buy |
10,967
+1,324
| +14% | +$140K | 0.05% | 111 |
|
|
2021
Q4 | $998K | Buy |
9,643
+620
| +7% | +$71.8K | 0.04% | 121 |
|
|
2021
Q3 | $1.13M | Buy |
9,023
+614
| +7% | +$79.5K | 0.05% | 110 |
|
|
2021
Q2 | $1.04M | Buy |
8,409
+689
| +9% | +$86.5K | 0.04% | 113 |
|
|
2021
Q1 | $912K | Sell |
7,720
-4,292
| -36% | -$503K | 0.04% | 113 |
|
|
2020
Q4 | $1.41M | Sell |
12,012
-559
| -4% | -$61.5K | 0.06% | 90 |
|
|
2020
Q3 | $1.31M | Buy |
12,571
+1,088
| +9% | +$109K | 0.07% | 90 |
|
|
2020
Q2 | $1.05M | Buy |
11,483
+458
| +4% | +$43.9K | 0.06% | 95 |
|
|
2020
Q1 | $994K | Buy |
11,025
+495
| +5% | +$52.7K | 0.06% | 89 |
|
|
2019
Q4 | $1.2M | Buy |
10,530
+5,487
| +109% | +$602K | 0.06% | 91 |
|
|
2019
Q3 | $548K | Buy |
5,043
+2,289
| +83% | +$239K | 0.03% | 123 |
|
|
2019
Q2 | $268K | Buy |
+2,754
| New | +$251K | 0.02% | 173 |
|
|
2019
Q1 | – | Sell |
-4,841
| Closed | -$440K | – | 216 |
|
|
2018
Q4 | $440K | Buy |
4,841
+1,001
| +26% | +$93.5K | 0.03% | 126 |
|
|
2018
Q3 | $378K | Buy |
+3,840
| New | +$355K | 0.03% | 135 |
|
|
2016
Q1 | – | Sell |
-42,723
| Closed | -$3.29M | – | 200 |
|
|
2015
Q4 | $3.29M | Buy |
42,723
+4,100
| +11% | +$309K | 0.31% | 81 |
|
|
2015
Q3 | $2.58M | Sell |
38,623
-236
| -0.6% | -$17.4K | 0.26% | 85 |
|
|
2015
Q2 | $2.88M | Sell |
38,859
-7,265
| -16% | -$555K | 0.28% | 86 |
|
|
2015
Q1 | $3.6M | Sell |
46,124
-136
| -0.3% | -$10.3K | 0.31% | 85 |
|
|
2014
Q4 | $3.34M | Sell |
46,260
-323
| -0.7% | -$22.4K | 0.31% | 83 |
|
|
2014
Q3 | $2.89M | Hold |
46,583
| – | – | 0.28% | 87 |
|
|
2014
Q2 | $2.97M | Buy |
46,583
+10,300
| +28% | +$626K | 0.29% | 84 |
|
|
2014
Q1 | $2.23M | Sell |
36,283
-509
| -1% | -$29.6K | 0.24% | 99 |
|
|
2013
Q4 | $2.11M | Buy |
36,792
+1
| +0% | +$57 | 0.25% | 99 |
|
|
2013
Q3 | $1.96M | Sell |
36,791
-7,877
| -18% | -$424K | 0.26% | 102 |
|
|
2013
Q2 | $2.3M | Buy |
+44,668
| New | +$2.21M | 0.33% | 90 |
|
Other funds holding MDT
Dearborn Partners's MDT Position: Q2 2026 in Review
Dearborn Partners reduced its Medtronic (MDT) stake by 9% in Q2 2026, selling an estimated $369K and leaving 46,112 shares worth $3.61M. The position accounts for 0.2% of the portfolio, ranked #80.
Dearborn Partners first reported a position in MDT in Q2 2013 and has held it in 42 quarters since. The position peaked at $8.93M in Q2 2023. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Dearborn Partners held 46,112 shares of Medtronic worth $3.61M as of Q2 2026.
- Dearborn Partners sold 4,579 Medtronic shares in Q2 2026, an estimated $369K.
- Medtronic made up 0.2% of Dearborn Partners's portfolio in Q2 2026, its #80 holding.
- Dearborn Partners first reported a position in Medtronic in Q2 2013 and has held it in 42 quarters since.
- Dearborn Partners's Medtronic position peaked at $8.93M in Q2 2023.
- 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Dearborn Partners's 13F filing for Q2 2026, filed 13 Aug 2026.